Aipoalani v. Derr

District Court, D. Hawaii·Decided July 21, 2022·No. 1:22-cv-00093·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF HAWAII HANALEI YUKUTARU AIPOALANI, CIVIL NO. 22-00093 DKW-RT #53121-509, ORDER DISMISSING SECOND Plaintiff, AMENDED COMPLAINT AND ACTION v.

ESTELA DERR, et al.,

Defendants.

Before the Court is a Second Amended Prisoner Civil Rights Complaint (“SAC”), ECF No. 10, filed by pro se Plaintiff Hanalei Yukutaru Aipoalani1 pursuant to Bivens v. Six Unknown Named Agents of Federal Bureau of Narcotics, 403 U.S. 388 (1971). Aipoalani alleges in the SAC that three officials2 at FDC Honolulu violated the Eighth Amendment by denying him adequate medical care. ECF No. 10 at 5–12.

1Aipoalani is currently incarcerated at the Federal Detention Center in Honolulu, Hawaii (“FDC Honolulu”). See ECF No. 10 at 1; Bureau of Prisons, https://www.bop.gov/inmateloc/ (select “Find By Number”; enter “53121-509” in “Number” field; and select “Search”) (last visited July 14, 2022).

2Aipoalani names as Defendants Warden Estela Derr (“Warden Derr”), Chief Medical Officer Nathan Kwon, M.D. (“Dr. Kwon”), and Nurse Practitioner R. Johnson (“Nurse Johnson”) in their individual capacities. ECF No. 10 at 1–2. As explained below, the SAC fails to state a claim upon which relief may be granted because Aipoalani has not plausibly alleged that any Defendant was

deliberately indifferent to a serious medical need. The SAC is therefore DISMISSED. See 28 U.S.C. §§ 1915(e)(2) & 1915A(b)(1). Because Aipoalani has had three opportunities to state a colorable claim for relief and has been unable

to do so, this dismissal is without leave to amend. This dismissal may count as a strike under 28 U.S.C. § 1915(g). I. STATUTORY SCREENING The Court is required to screen all in forma pauperis prisoner pleadings

against government officials pursuant to 28 U.S.C. §§ 1915(e)(2) and 1915A(a). See Byrd v. Phx. Police Dep’t, 885 F.3d 639, 641 (9th Cir. 2018). Claims or complaints that are frivolous, malicious, fail to state a claim for relief, or seek

damages from defendants who are immune from suit must be dismissed. See Lopez v. Smith, 203 F.3d 1122, 1126–27 (9th Cir. 2000) (en banc); Rhodes v. Robinson, 621 F.3d 1002, 1004 (9th Cir. 2010). Screening under 28 U.S.C. §§ 1915(e)(2) and 1915A(a) involves the same

standard of review as that used under Federal Rule of Civil Procedure 12(b)(6). See Rosati v. Igbinoso, 791 F.3d 1037, 1039 (9th Cir. 2015) (per curiam). Under this standard, a complaint must “contain sufficient factual matter, accepted as true,

to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (internal quotation marks and citation omitted). A claim is “plausible” when the facts alleged support a reasonable inference that the plaintiff

is entitled to relief from a specific defendant for specific misconduct. See id. In conducting this screening, the Court liberally construes pro se litigants’ pleadings and resolves all doubts in their favor. See Hebbe v. Pliler, 627 F.3d 338,

342 (9th Cir. 2010) (citations omitted). The Court must grant leave to amend if it appears the plaintiff can correct the defects in the complaint. See Lopez, 203 F.3d at 1130. When a claim cannot be saved by amendment, dismissal with prejudice is appropriate. See Sylvia Landfield Tr. v. City of Los Angeles, 729 F.3d 1189, 1196

(9th Cir. 2013). II. BACKGROUND3 A. First COVID-19 Infection

Aipoalani was fully vaccinated against COVID-19 when he self-surrendered at FDC Honolulu on August 11, 2021. ECF No. 10 at 6. He was initially housed in a “Quarantine unit” with an inmate who was unvaccinated and who had not been tested for the virus. Id. at 6. That inmate experienced nausea, chills, and migraine

headaches between August 11–13. Id. On August 14, officials moved Aipoalani to another cell. Id.

3At screening, Aipoalani’s well-pleaded factual allegations are accepted as true. See, e.g., Nordstrom v. Ryan, 762 F.3d 903, 908 (9th Cir. 2014). Aipoalani’s former cellmate tested positive for COVID-19 on August 16, and, the following day, Aipoalani tested positive for the virus. Id. Prison officials

immediately moved Aipoalani to “health services” for isolation and observation. Id. On August 18, prison officials moved Aipoalani to a “newly designated isolation unit.” Id. at 6. Aipoalani remained in isolation until August 28, 2021.

Id. at 8. While in isolation, Aipoalani submitted at least eight informal complaints. Id. at 6. These complaints related to the fact that Aipoalani had been housed with an inmate who caught the virus. Id. at 6, 9. On September 13, 2021, Aipoalani

submitted to Warden Derr a “Request for Compassionate Release/Reduction in Sentence.” Id. at 6. In his request, Aipoalani noted that he had contracted COVID-19 and that he was living with hypertension. Id.

B. Hypertension Aipoalani had been diagnosed with hypertension at some point before he arrived at FDC Honolulu. Id. at 8. Aipoalani’s outside doctor had prescribed the drug Lisinopril to treat the condition. Id. During Aipoalani’s initial health

assessment at FDC Honolulu, Dr. Kwon also wrote Aipoalani a prescription for Lisinopril. Id. After Aipoalani tested positive for COVID-19 and was moved to isolation

on August 18, Nurse Johnson performed another health assessment. Id. During this assessment, Nurse Johnson suspected that Aipoalani might be allergic to Lisinopril. Id. Nurse Johnson issued an order, co-signed by Dr. Kwon,

discontinuing Aipoalani’s prescription for Lisinopril. Id. In its place, Nurse Johnson prescribed Losartan, another drug used to treat hypertension. Id. Nurse Johnson saw Aipoalani again on September 3, 2021. Id. During that

visit, Nurse Johnson prescribed an additional hypertension medication, Hydrochlorothiazide. Id. On October 21, 2021, another prison official prescribed a third medication, Amlodipine, to treat Aipoalani’s hypertension. Id. When Nurse Johnson saw Aipoalani again on November 17, 2021, Nurse Johnson

doubled his dose of Amlodipine. Id. Dr. Kwon saw Aipoalani again on November 30, 2021. Id. During this visit, Dr. Kwon prescribed Metformin to treat Aipoalani’s diabetes and

Atorvastatin to treat his high cholesterol. Id. Although Aipoalani had submitted informal complaints to Dr. Kwon on October 21, 2021, and November 5 and 6, 2021, describing other symptoms, including blurred vision, hearing loss, and fatigue, Aipoalani does not allege that he reported any of these issues, or any issues

related to his hypertension, to Dr. Kwon during the November 30, 2021 appointment. Aipoalani submitted additional informal complaints to Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Aipoalani v. Derr, (D. Haw. 2022).

Aipoalani v. Derr (Aipoalani v. Derr) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Coppedge v. United States
369 U.S. 438 (Supreme Court, 1962)
Davis v. Passman
442 U.S. 228 (Supreme Court, 1979)
Carlson v. Green
446 U.S. 14 (Supreme Court, 1980)
Chappell v. Wallace
462 U.S. 296 (Supreme Court, 1983)
Bush v. Lucas
462 U.S. 367 (Supreme Court, 1983)
United States v. Stanley
483 U.S. 669 (Supreme Court, 1987)
Schweiker v. Chilicky
487 U.S. 412 (Supreme Court, 1988)
Federal Deposit Insurance v. Meyer
510 U.S. 471 (Supreme Court, 1994)
Correctional Services Corp. v. Malesko
534 U.S. 61 (Supreme Court, 2001)
Hui v. Castaneda
559 U.S. 799 (Supreme Court, 2010)
Wilkie v. Robbins
551 U.S. 537 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Hebbe v. Pliler
627 F.3d 338 (Ninth Circuit, 2010)
Rhodes v. Robinson
621 F.3d 1002 (Ninth Circuit, 2010)
Walter Rodenhurst, Iii v. Kay Bauman
509 F. App'x 634 (Ninth Circuit, 2013)
Sylvia Landfield Trust v. City of Los Angeles
729 F.3d 1189 (Ninth Circuit, 2013)